NCT00767104

Brief Summary

The purpose of this research study is to better understand how this study pillowcase works when people use it to treat acne. Most people, including people with acne, sleep six to eight hours each night in direct contact with bedding fabrics that provide no benefit to the healing process associated with acne. The fabric in this study pillowcase may be able to reduce bacteria on the skin. This study would evaluate how acne is affected by this silk-like pillowcase. This type of study has not been done before.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2008

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2008

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

October 3, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 6, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2009

Completed
8.1 years until next milestone

Results Posted

Study results publicly available

April 10, 2017

Completed
Last Updated

September 11, 2018

Status Verified

August 1, 2018

Enrollment Period

5 months

First QC Date

October 3, 2008

Results QC Date

November 12, 2010

Last Update Submit

August 13, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total Lesion Count

    The number of papules, pustules and cysts at Week 12.

    12 weeks

Secondary Outcomes (1)

  • % Reduction in Total Lesion Count

    12 weeks

Study Arms (2)

Silk-Like Pillowcase

EXPERIMENTAL

Silk- Like pillowcase-One-half of subjects will be assigned to sleep on the study product, which is a standard size pillowcase made of a silk-like fabric every night for 12 weeks. The study pillowcases are fabricated from a light-weight plain-weave fabric woven of 100 percent synthetic yarns. The fabric is comprised of approximately 50% polyester and 50% nylon. The yarns in the fabric are formed from continuous-filament fibers, with no fibers projecting beyond the planar surface of the fabric. The antimicrobial technology used in the fabric is incorporated into the fibers during the finishing process and does not migrate out of the fabric or cause adverse reactions with skin contact.

Other: Silk like Pillowcase

Cotton Pillowcase

PLACEBO COMPARATOR

Placebo Comparator-One-half of subjects will be assigned to sleep on the placebo pillow case every night for 12 weeks. Placebo pillowcase is made of 100% cotton

Other: Cotton Pillowcase

Interventions

sleep on silk-like pillowcase each night

Silk-Like Pillowcase

Sleep on placebo cotton pillowcase each night

Cotton Pillowcase

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female with facial acne vulgaris, 12 years of age or older, that agree to participate and provide written consent
  • Greater than 5 superficial inflammatory lesions with less than 3 nodules on the face
  • A score of 2-4 on the Investigator Global Assessment
  • Women of childbearing potential will be allowed to participate in the study, and these subjects will be required to use at least one form of birth control
  • Female subjects will have a urine pregnancy test if applicable.

You may not qualify if:

  • Use within 4 weeks of baseline of systemic anti-inflammatory medication, which may influence study outcome, such as systemic corticosteroids
  • Application or use within 2 weeks of baseline of topical acne or rosacea medications or topical anti-inflammatory medication, which may influence study outcome
  • Presence of a concurrent medical condition, which is determined by the investigator to potentially interfere with study outcomes or patient assessments
  • Subjects who have taken isotretinoin within the past 6 months
  • Subjects with known allergy or sensitivity to polyester or nylon fibers in fabric
  • Pregnant women and women who are breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Acne Vulgaris

Condition Hierarchy (Ancestors)

Acneiform EruptionsSkin DiseasesSkin and Connective Tissue DiseasesSebaceous Gland Diseases

Limitations and Caveats

Results limited by low number of participants.

Results Point of Contact

Title
Alan Fleischer, Jr. MD
Organization
Wake Forest University Health Sciences

Study Officials

  • Alan B Fleischer, MD

    Wake Forest University Health Sciences, Dermatology

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 3, 2008

First Posted

October 6, 2008

Study Start

October 1, 2008

Primary Completion

March 1, 2009

Study Completion

March 1, 2009

Last Updated

September 11, 2018

Results First Posted

April 10, 2017

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share